<DOC>
	<DOCNO>NCT02666352</DOCNO>
	<brief_summary>This 2-part , non-randomized , open-label , single-dose study evaluate pharmacokinetics ( PK ) MK-3682 , metabolites M5 M6 , ruzasvir ( MK-8408 ) participant moderate hepatic insufficiency ( HI ) ( Part 1 ) participant severe HI ( Part 2 ) compare match healthy particpants .</brief_summary>
	<brief_title>A Study Pharmacokinetics MK-3682 Ruzasvir ( MK-8408 ) Participants With Moderate Severe Hepatic Insufficiency ( MK-3682-029 )</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Hepatic Insufficiency</mesh_term>
	<criteria>HI Participants Only : Has diagnosis chronic ( &gt; 6 month ) , stable ( acute episode illness within previous 2 month due deterioration hepatic function ) HI feature cirrhosis ; Part 1 : Participant 's score ChildPugh scale range 7 9 ( moderate HI ) study start . Part 2 : Participant 's score ChildPugh scale range 10 15 ( severe HI ) study start . All Participants : Body mass index ( BMI ) ≥19 ≤ 40 kg/m^2 ; Continuous nonsmoker moderate smoker ( few 20 cigarettes/day equivalent ) . Participants must agree consume 10 cigarette equivalent/day time screen throughout period sample collection ; Health judge stable base medical history ( except hepatic impairment condition ) , physical examination , vital sign , electrocardiogram ( ECGs ) , laboratory safety test ; For female participant childbearing potential : either sexually inactive 14 day prior study start throughout study use acceptable birth control method ; Female participant sexually inactive , become sexually active course study must agree use double physical barrier method ( e.g. , condom diaphragm ) chemical barrier ( e.g. , spermicide ) time start sexual activity completion study ; Vasectomized nonvasectomized male participant must agree use condom spermicide abstain sexual intercourse dose 90 day dose ; Male participant must agree donate sperm dose 90 day dose ; Able swallow multiple tablet capsule . HI Participants Only : Presence moderate severe renal insufficiency ( estimate glomerular filtration rate [ eGFR ] ≤50 mL/min/1.73 m^2 calculate accord Modification Diet Renal Disease [ MDRD ] study equation ) ; Presence drug abuse within past 6 month prior dose . Healthy Participants Only : Presence moderate severe renal insufficiency ( eGFR ≤60 mL/min/1.73 m^2 calculate accord MDRD study equation ) ; History presence alcoholism drug abuse within past 2 year prior dose ; All Participants : Is mentally legally incapacitated significant emotional problem time study start expect study ; History presence clinically significant medical psychiatric condition disease ; History presence hypersensitivity idiosyncratic reaction study drug related compound ; Female participant pregnant lactating ; Positive result study start human immunodeficiency virus ( HIV ) , hepatitis B surface antigen ( HBsAg ) hepatitis C virus ( HCV ) ; Unable refrain anticipates use medication substance ( include prescription overthecounter , vitamin supplement , natural herbal supplement ) prohibit time period ; Has take amiodarone time life ; Donation blood &gt; 500 mL significant blood loss within 56 day prior dose study drug ; Plasma donation within 7 day prior dose study drug ; Dosed another clinical trial within 28 day prior dose study drug ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>